Pfizer: Diabetes Mellitus trials
The registry lists 35 Diabetes Mellitus studies with Pfizer as lead sponsor. 2 are open to participants now and 15 have results posted.
Phase 1 10Phase 2 8Phase 3 13Phase 4 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)RecruitingNCT07915609Phase 3
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruitingNCT07595549Phase 3
- Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With ObesityTerminatedNCT05579977Phase 2Results posted
- A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITYCompletedNCT04617275Phase 2Results posted
- A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular EdemaTerminatedNCT01994291Phase 2Results posted
- A 2-week Trial Of PF-04991532 In Patients With Type 2 DiabetesCompletedNCT01469065Phase 1Results posted
- Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult FemalesCompletedNCT01301456Phase 1Results posted
- Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On MetforminCompletedNCT00970593Phase 1Results posted
- Follow-Up Study for ExuberaCompletedNCT00734591Results posted
- A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.CompletedNCT00605280Phase 2/3Results posted
- Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 DiabetesTerminatedNCT00527397Phase 3Results posted
- Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular SafetyCompletedNCT00359801Phase 4Results posted
- Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 DiabetesCompletedNCT00348374Phase 3Results posted
- Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes MellitusTerminatedNCT00143247Phase 2Results posted
- A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With AsthmaCompletedNCT00139659Phase 3Results posted
- A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPDTerminatedNCT00138671Phase 3Results posted
- Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 DiabetesTerminatedNCT00136916Phase 3Results posted
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Active, not recruitingNCT07400653Phase 3
- Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedNCT01757756Phase 1
- Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532CompletedNCT01469481Phase 1
- A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532CompletedNCT01369277Phase 1
- Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With HypertensionWithdrawnNCT01260857
- Multiple Dose Study of PF-04991532 in Patients With Type 2 DiabetesCompletedNCT01129258Phase 1
- Single Dose Study of PF-04991532 in Healthy SubjectsCompletedNCT01102673Phase 1
- A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)WithdrawnNCT00457470Phase 2
- Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male SubjectsCompletedNCT00448032Phase 1
- Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the HeartCompletedNCT00447629Phase 1
- Study Evaluating PPM-204 In Subjects With Type 2 DiabetesTerminatedNCT00425919Phase 2
- A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose DispositionTerminatedNCT00287066Phase 3
- The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.TerminatedNCT00280085Not applicable
- Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling GlucoseCompletedNCT00150410Phase 3
- A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart DiseaseTerminatedNCT00134264Phase 3
- A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose ControlCompletedNCT00134147Phase 3
- Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic NeuropathyTerminatedNCT00073034Phase 2
- Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot InfectionsCompletedNCT00044746Phase 4